Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group.

McKinney RE Jr, Maha MA, Connor EM, Feinberg J, Scott GB, Wulfsohn M, McIntosh K, Borkowsky W, Modlin JF, Weintrub P, et al.

N Engl J Med. 1991 Apr 11;324(15):1018-25.

PMID:
1672443
[PubMed - indexed for MEDLINE]
Free Article
2.

Dideoxyinosine in children with symptomatic human immunodeficiency virus infection.

Butler KM, Husson RN, Balis FM, Brouwers P, Eddy J, el-Amin D, Gress J, Hawkins M, Jarosinski P, Moss H, et al.

N Engl J Med. 1991 Jan 17;324(3):137-44.

PMID:
1670591
[PubMed - indexed for MEDLINE]
Free Article
3.

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.

Volberding PA, Lagakos SW, Koch MA, Pettinelli C, Myers MW, Booth DK, Balfour HH Jr, Reichman RC, Bartlett JA, Hirsch MS, et al.

N Engl J Med. 1990 Apr 5;322(14):941-9.

PMID:
1969115
[PubMed - indexed for MEDLINE]
Free Article
4.

Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group.

McKinney RE Jr, Pizzo PA, Scott GB, Parks WP, Maha MA, Lehrman SN, Riggs M, Eddy J, Lane BA, Eppes SC, et al.

J Pediatr. 1990 Apr;116(4):640-7.

PMID:
2181102
[PubMed - indexed for MEDLINE]
5.

A pilot study of low-dose zidovudine in human immunodeficiency virus infection.

Collier AC, Bozzette S, Coombs RW, Causey DM, Schoenfeld DA, Spector SA, Pettinelli CB, Davies G, Richman DD, Leedom JM, et al.

N Engl J Med. 1990 Oct 11;323(15):1015-21.

PMID:
1977080
[PubMed - indexed for MEDLINE]
Free Article
6.

A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.

Fischl MA, Parker CB, Pettinelli C, Wulfsohn M, Hirsch MS, Collier AC, Antoniskis D, Ho M, Richman DD, Fuchs E, et al.

N Engl J Med. 1990 Oct 11;323(15):1009-14.

PMID:
1977079
[PubMed - indexed for MEDLINE]
Free Article
7.

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.

Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R.

Pediatrics. 2002 Feb;109(2):E25.

PMID:
11826235
[PubMed - indexed for MEDLINE]
8.

Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine.

Miles SA, Mitsuyasu RT, Moreno J, Baldwin G, Alton NK, Souza L, Glaspy JA.

Blood. 1991 May 15;77(10):2109-17.

PMID:
1709368
[PubMed - indexed for MEDLINE]
Free Article
9.

A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.

Spector SA, Gelber RD, McGrath N, Wara D, Barzilai A, Abrams E, Bryson YJ, Dankner WM, Livingston RA, Connor EM.

N Engl J Med. 1994 Nov 3;331(18):1181-7.

PMID:
7935655
[PubMed - indexed for MEDLINE]
Free Article
10.

Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study.

Meng TC, Fischl MA, Boota AM, Spector SA, Bennett D, Bassiakos Y, Lai SH, Wright B, Richman DD.

Ann Intern Med. 1992 Jan 1;116(1):13-20.

PMID:
1345755
[PubMed - indexed for MEDLINE]
11.

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.

Fischl MA, Richman DD, Hansen N, Collier AC, Carey JT, Para MF, Hardy WD, Dolin R, Powderly WG, Allan JD, et al.

Ann Intern Med. 1990 May 15;112(10):727-37.

PMID:
1970466
[PubMed - indexed for MEDLINE]
12.

Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)

Krown SE, Gold JW, Niedzwiecki D, Bundow D, Flomenberg N, Gansbacher B, Brew BJ.

Ann Intern Med. 1990 Jun 1;112(11):812-21. Erratum in: Ann Intern Med 1990 Aug 15;113(4):334.

PMID:
1971504
[PubMed - indexed for MEDLINE]
13.

A randomized comparative trial of stavudine (d4T) versus zidovudine (ZDV, AZT) in children with human immunodeficiency virus infection. AIDS Clinical Trials Group 240 Team.

Kline MW, Van Dyke RB, Lindsey JC, Gwynne M, Culnane M, McKinney RE Jr, Nichols S, Mitchell WG, Yogev R, Hutcheon N.

Pediatrics. 1998 Feb;101(2):214-20.

PMID:
9445494
[PubMed - indexed for MEDLINE]
14.

Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection.

Pizzo PA, Eddy J, Falloon J, Balis FM, Murphy RF, Moss H, Wolters P, Brouwers P, Jarosinski P, Rubin M, et al.

N Engl J Med. 1988 Oct 6;319(14):889-96.

PMID:
3166511
[PubMed - indexed for MEDLINE]
15.

Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team.

Englund JA, Baker CJ, Raskino C, McKinney RE, Petrie B, Fowler MG, Pearson D, Gershon A, McSherry GD, Abrams EJ, Schliozberg J, Sullivan JL.

N Engl J Med. 1997 Jun 12;336(24):1704-12.

PMID:
9182213
[PubMed - indexed for MEDLINE]
Free Article
16.

[Results of zidovudine treatment of 9 vertically HIV infected children].

Berkefeld I, Fuchs A, Wahn V.

Monatsschr Kinderheilkd. 1993 Jun;141(6):498-504. German.

PMID:
8101636
[PubMed - indexed for MEDLINE]
17.

A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infection.

Kline MW, Dunkle LM, Church JA, Goldsmith JC, Harris AT, Federici ME, Schultze ME, Woods L, Loewen DF, Kaul S, et al.

Pediatrics. 1995 Aug;96(2 Pt 1):247-52.

PMID:
7630678
[PubMed - indexed for MEDLINE]
18.

Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex.

Skowron G, Bozzette SA, Lim L, Pettinelli CB, Schaumburg HH, Arezzo J, Fischl MA, Powderly WG, Gocke DJ, Richman DD, Pottage JC, Antoniskis D, McKinley GF, Hyslop NE, Ray G, Simon G, Reed N, LoFaro ML, Uttamchandani RB, Gelb LD, Sperber SJ, Murphy RL, Leedom JM, Grieco MH, Zachary J, Hirsch MS, Spector SA, Bigley J, Soo W, Merigan TC.

Ann Intern Med. 1993 Mar 1;118(5):321-30.

PMID:
8094279
[PubMed - indexed for MEDLINE]
19.

Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group.

Cooper DA, Gatell JM, Kroon S, Clumeck N, Millard J, Goebel FD, Bruun JN, Stingl G, Melville RL, González-Lahoz J, et al.

N Engl J Med. 1993 Jul 29;329(5):297-303.

PMID:
8100611
[PubMed - indexed for MEDLINE]
Free Article
20.

A controlled trial of zidovudine in primary human immunodeficiency virus infection.

Kinloch-De Loës S, Hirschel BJ, Hoen B, Cooper DA, Tindall B, Carr A, Saurat JH, Clumeck N, Lazzarin A, Mathiesen L, et al.

N Engl J Med. 1995 Aug 17;333(7):408-13. Erratum in: N Engl J Med 1995 Nov 16;333(20):1367.

PMID:
7616989
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk